FDA/CMS Discussing Liaison Office To Improve Coverage Decisions

FDA is considering the creation of a liaison office to provide guidance to the Centers for Medicare & Medicaid Services on federal coverage decisions for new products

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet